PAX8 and differentiated thyroid carcinoma: PAX8 cannot be utilised to distinguish between primary cancer from renal cell carcinoma (92% positive) and primary thyroid tumours such as papillary thyroid carcinoma, which stains for PAX8 100% of the time [3,9,78].